(Per)fluoropolyether polymers comprising a (per)fluoropolyether chain having two ends, wherein one or both ends comprise one or more zwitterionic groups at one or both polymer ends, methods for their manufacture and uses thereof are herein disclosed. The polymers can be used in particular for protecting materials in contact with biological fluids or fluids containing biological material from contamination by organic compounds therein contained.

A photo curable ink composition includes a photo-reactive binder, a water soluble polymeric sensitizer, a water soluble photoinitiator, a colorant, and a balance of water. The water soluble polymeric sensitizer includes a functionalized anthrone moiety, a polyether chain, and an amide linkage or an ether linkage attaching one end of the polyether chain to the functionalized anthrone moiety. The water soluble photoinitiator having a formula (I) of: wherein n is any integer from 1 to 5 and M is a metal with a valence from 1 to 5.

Described herein is a method for producing a coating system on a substrate, including producing a cured basecoat film on the substrate by applying a pigmented aqueous basecoat material to the substrate and subsequently curing the basecoat material, wherein the basecoat material includes a polyether-based reaction product which is preparable by reaction of (a) at least one cyclic tetracarboxylic dianhydride having an aliphatic, aromatic or araliphatic radical X which bridges the two anhydride groups,
with (b) at least one polyether of a general structural formula (II)

##STR00001##

in which R is a C.sub.3 to C.sub.6 alkylene radical and n is selected such that the polyether (b) possesses a number-average molecular weight of 500 to 5000 g/mol, and wherein components (a) and (b) are used in the reaction in a molar ratio of 0.7/2.3 to 1.6/1.7 and a resulting reaction product possesses an acid number of 5 to 80 mg KOH/g.

Embodiments of the invention are directed to a macromolecular chemotherapeutic. A non-limiting example of the macromolecular chemotherapeutic includes a block copolymer. The block copolymer can include a water-soluble block, a cationic block, and a linker, wherein the linker is connected to the water-soluble bock and the charged block.

This invention relates to a bridged polyethylene glycol-aliphatic polyester block copolymer, which can be used in the production of delivery carriers for micromolecular chemotherapeutic drugs and nucleic acid drugs. Nanoscale pharmaceutical carriers produced from the bridged block polymer may be subjected to specific degradation under pH environments in tumor tissues or tumor cells so as to change the structure of nanoparticles, enhance cell uptake or intracellular drug release, and improve the sensitivity of tumor cells to drugs.

Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.

This disclosure relates to polymersomes comprising a crosslinked polymer and their use as drug delivery vehicles. Specifically, polymersomes comprising a polymer of Formula I: ##STR00001##
wherein each R is independently C.sub.1-6 alkyl; and n is an integer between 1 and 50.

The present invention relates to micellar nanocomplexes and a method of forming the same. The micellar nanocomplex comprises a micelle and an agent encapsulated within said micelle, where the micelle comprises a polymer-flavonoid conjugate, wherein said polymer is bonded to the B ring of said flavonoid. The micellar nanocomplex may have useful applications as a drug-delivery system.

A composition in a water-in-oil-in-water (W/O/W) emulsion is disclosed. The composition comprises: (a) a continuous aqueous phase, comprising H.sub.2O; (b) an oil phase or an oil shell, dispersed in the continuous aqueous phase; and (c) a hydrophilic polymer, stabilizing an interface between the continuous aqueous phase and the oil phase or the oil shell to form the water-in-oil-in-water (W/O/W) emulsion. The oil phase or the oil shell comprises: (i) oil; (ii) an internal aqueous phase, dispersed within the oil or the oil shell; and (iii) a lipophilic sorbitan-polyester conjugate, stabilizing an interface between the oil and the inner aqueous phase to form a water-in-oil (W/O) emulsion. The lipophilic sorbitan-polyester conjugate comprises: (1) sorbitan; and (2) poly(lactide-co--caprolactone) or polylactic acid (polylactide), conjugated to the sorbitan.

(Per)fluoropolyether polymers comprising a (per)fluoropolyether chain having two ends, wherein one or both ends comprise one or more zwitterionic groups at one or both polymer ends, methods for their manufacture and uses thereof are herein disclosed. The polymers can be used in particular for protecting materials in contact with biological fluids or fluids containing biological material from contamination by organic compounds therein contained.